The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
We look back at some of the stories, people and events that stood out in 2014.
Italian vodka, suspicious sediment and antifreeze sold as spirits are among the potential danger signs for shoppers stocking up on alcohol.
Any showers in the north will clear away quickly to leave a dry and bright day with plenty of sunny spells.